A Comparison of LY2963016 to a Basal Insulin After a Single Dose in Healthy Subjects
Status:
Completed
Trial end date:
2011-07-01
Target enrollment:
Participant gender:
Summary
The purposes of this study are to determine the pharmacokinetics and pharmacodynamics of
LY2963016 compared to those of basal insulin. The study will also gather information on the
safety and tolerability of LY2963016 in healthy subjects. The study is approximately 12
weeks.